fda declares semaglutide shortage over Drug compounders sue declaration ending Wegovy FDA says Wegovy and Ozempic

A compound isolated from the reptiles saliva was found to bind to human GLP-1 receptors, with the added perk that it was slow to break down in the body

GLP-1R agonists have hence been examined as a potential therapy for diabetes, neurodegeneration and vision loss in Wolfram syndrome [21,22,23,24,25,26]

Poor Solubility of CoQ10 : In its native state, CoQ10 exhibits negligible aqueous solubility, requiring incorporation into mixed micelles with bile salts before absorption can begin

Read the full review via bit.ly/4qWDn05 #GItwitter #GLP1 This study reviews existing research on the use of GLP-1 receptor agonists in managing GI diseases and finds that early evidence suggests these agents hold promise across multiple conditions

About 82% of people taking tirzepatide achieved at least 5% weight loss after one year, compared to 67% of those on semaglutide

I respectfully disagree